Eugene Ahn MD

Summary

• I have been practicing integrative breast oncology now for 17 years (2024) and counting, and I have spent half of my career in academics (University of Miami) and half of my career in the for-profit industry (Cancer Treatment Centers of America) where I served as their Enterprise Medical Director and helped CTCA become a top enroller for the ASCO TAPUR study, the first basket study run by ASCO utilizing over 18 FDA approved drugs to be used in other cancer types/indications. I am now returned to academics, and serve as an Associate Professor at the Cardinal Bernadin Cancer Center with Loyola University Medical Center. I typically see patients exclusively with breast cancer, but I am available for integrative medicine consultations for any patient looking for local resources and integrative modalities to complement their conventional cancer treatment even if they are not being seen at Loyola. I am passionate about empowering patients to be their own healer, and I included here on my Doximity profile: a video/webinar I did for SIO as a good representation of how I look to protect my patients from 'life'.

April 12, 2025 Saturday: Bridging the Gaps Between Primary Care and Oncology
7:30am-3pm at the CTRE auditorium on Loyola Maywood IL campus, CME event about advances in cancer care and prevention. QR code attached. Hope to see you there.

SIO Webinar: COVID-19 and Vitamin D Deficiency: Evidence for Routine Testing and
Integrative Breast Oncologist Eugene Ahn MD reviews the scientific evidence that highlight the importance of vitamin D supplementation during COVID19